- Home
- IGC vs BNZI Comparison
IGC vs BNZI Comparison
Compare IGC & BNZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- BNZI
- Stock Information
- Founded
- IGC 2005
- BNZI 2016
- Country
- IGC United States
- BNZI United States
- Employees
- IGC N/A
- BNZI N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- BNZI
- Sector
- IGC Health Care
- BNZI
- Exchange
- IGC Nasdaq
- BNZI Nasdaq
- Market Cap
- IGC 20.2M
- BNZI 16.5M
- IPO Year
- IGC N/A
- BNZI N/A
- Fundamental
- Price
- IGC $0.31
- BNZI $0.69
- Analyst Decision
- IGC Strong Buy
- BNZI Strong Buy
- Analyst Count
- IGC 2
- BNZI 1
- Target Price
- IGC $3.88
- BNZI $24.00
- AVG Volume (30 Days)
- IGC 230.9K
- BNZI 3.7M
- Earning Date
- IGC 08-07-2025
- BNZI 08-13-2025
- Dividend Yield
- IGC N/A
- BNZI N/A
- EPS Growth
- IGC N/A
- BNZI N/A
- EPS
- IGC N/A
- BNZI N/A
- Revenue
- IGC $1,236,000.00
- BNZI $6,827,490.00
- Revenue This Year
- IGC N/A
- BNZI $570.18
- Revenue Next Year
- IGC $16.45
- BNZI $34.44
- P/E Ratio
- IGC N/A
- BNZI N/A
- Revenue Growth
- IGC 1.65
- BNZI 52.95
- 52 Week Low
- IGC $0.25
- BNZI $0.57
- 52 Week High
- IGC $0.55
- BNZI $11.20
- Technical
- Relative Strength Index (RSI)
- IGC 49.31
- BNZI 35.39
- Support Level
- IGC $0.30
- BNZI $0.57
- Resistance Level
- IGC $0.32
- BNZI $1.04
- Average True Range (ATR)
- IGC 0.02
- BNZI 0.11
- MACD
- IGC -0.00
- BNZI -0.02
- Stochastic Oscillator
- IGC 20.00
- BNZI 25.81
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.